NASDAQ: TECHBio Techne Corp Stock Ownership - Who owns Bio Techne?
Insider buying vs selling
Have Bio Techne Corp insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Shane Bohnen | SVP - General Counsel | 2025-04-03 | 747 | $54.86 | $40.98kSell |
| Amy E. Herr | Director | 2025-02-14 | 1,860 | $65.96 | $122.69kSell |
| Amy E. Herr | Director | 2025-02-14 | 1,976 | $44.33 | $87.60kBuy |
| Matthew McManus | President - DGS | 2025-02-01 | 1,642 | $73.55 | $120.77kSell |
| William Geist | PRESIDENT PROTEIN SCIENCES | 2025-02-01 | 1,109 | $73.55 | $81.57kSell |
| Kim Kelderman | Chief Executive Officer | 2025-01-27 | 1,661 | $77.95 | $129.48kSell |
| Kim Kelderman | Chief Executive Officer | 2025-01-27 | 11,731 | $77.19 | $905.54kSell |
| Kim Kelderman | Chief Executive Officer | 2025-01-27 | 13,392 | $37.70 | $504.88kBuy |
| Kim Kelderman | Chief Executive Officer | 2024-11-01 | 2,430 | $75.31 | $183.00kSell |
| James Hippel | CFO | 2024-11-01 | 6,475 | $75.31 | $487.63kSell |
TECH insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when TECH insiders and whales buy or sell their stock.
TECH Shareholders
What type of owners hold Bio Techne Corp stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vanguard Group Inc | 11.76% | 18,594,608 | $894.40M | Institution |
| Blackrock Inc | 8.88% | 14,036,494 | $675.16M | Institution |
| Price T Rowe Associates Inc | 6.74% | 10,654,267 | $512.47M | Institution |
| State Street Corp | 4.09% | 6,472,680 | $311.34M | Institution |
| Morgan Stanley | 3.01% | 4,758,525 | $228.89M | Institution |
| Ameriprise Financial Inc | 2.97% | 4,702,942 | $226.21M | Institution |
| Bamco Inc | 2.62% | 4,136,984 | $198.99M | Institution |
| Geode Capital Management LLC | 2.53% | 4,001,296 | $192.46M | Institution |
| Invesco Ltd | 2.42% | 3,820,464 | $183.76M | Institution |
| Neuberger Berman Group LLC | 2.27% | 3,581,778 | $172.28M | Institution |
TECH vs Biotech Stocks
Bio Techne Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.